Healthy Living/WellnessFDA Approves Alkermes' Aristada Drug As Schizophrenia Treatment Alkermes announced that the FDA has approved its extended-release injectable for schizophrenia treatment. Aristada, poised to be launched immediately, will offer once-a-month and six-week dosing options.by Katrina Pascual
Healthy Living/Wellness10-Year-Old Child Dies From Allergic Reaction After Drinking Coconut Milkby Katrina Pascual
Healthy Living/WellnessMiracle Surgery: Doctors Reattach Toddler's Decapitated Head After Car Accidentby Rhodi Lee
Healthy Living/Wellness13 Million Americans are Mentally Ill: Groups Urge Legislators To Reform U.S. Mental Health Systemby Katherine Derla
Healthy Living/WellnessGeneral Mills Recalls 2nd Batch Of Frozen Green Beans Due To Listeriaby Rina Marie Doctor
Healthy Living/WellnessAnother Reason To Play Action Video Games: It's Good For Your Brain, Says Studyby Rhodi Lee
Healthy Living/WellnessScientists Working On A Pill That Can Mimic The Effects Of Exerciseby Rhodi Lee
Healthy Living/WellnessCatholic Healthcare Group Faces Charges For Refusing To Provide Abortionsby Katherine Derla
Healthy Living/WellnessFDA Warns Heart Device Maker St. Jude About Nonconforming Manufacturing Practices At Atlanta Plantby Katrina Pascual
Healthy Living/WellnessBrazil Suspends Production And Sale Of Breast Implant Maker Silimed Products Due To Safety Risksby Katrina Pascual